Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 199.76M
March 31, 2026 217.40M
December 31, 2025 212.54M
September 30, 2025 203.79M
June 30, 2025 189.69M
March 31, 2025 178.14M
December 31, 2024 182.76M
September 30, 2024 172.71M
June 30, 2024 177.06M
March 31, 2024 130.63M
December 31, 2023 108.45M
September 30, 2023 68.24M
June 30, 2023 45.20M
March 31, 2023 65.43M
December 31, 2022 66.09M
September 30, 2022 88.61M
June 30, 2022 87.42M
March 31, 2022 90.23M
December 31, 2021 116.46M
September 30, 2021 105.41M
June 30, 2021 132.52M
March 31, 2021 130.51M
December 31, 2020 115.99M
September 30, 2020 96.34M
June 30, 2020 43.82M
Date Value
March 31, 2020 15.77M
December 31, 2019 -3.684M
September 30, 2019 -3.162M
June 30, 2019 16.59M
March 31, 2019 23.78M
December 31, 2018 20.20M
September 30, 2018 23.18M
June 30, 2018 7.56M
March 31, 2018 8.006M
December 31, 2017 21.53M
September 30, 2017 22.24M
June 30, 2017 31.01M
March 31, 2017 22.77M
December 31, 2016 18.54M
September 30, 2016 8.676M
June 30, 2016 5.635M
March 31, 2016 7.368M
December 31, 2015 16.54M
September 30, 2015 27.59M
June 30, 2015 31.07M
March 31, 2015 27.90M
December 31, 2014 17.43M
September 30, 2014 11.76M
June 30, 2014 7.434M
March 31, 2014 6.532M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Globus Medical, Inc. 750.84M
Baxter International, Inc. 812.00M
DexCom, Inc. 1.405B
Haemonetics Corp. 291.22M
ICU Medical, Inc. 144.84M